Anna Planagumà
Anna Planagumà publishes mostly in Pharmacology, Biochemistry and Physiology, on topics such as Eicosanoids and Hypertension Pharmacology, Inflammatory mediators and NSAID effects and Asthma and respiratory diseases.
- World rank
- #1,264,391 of 7,710,434 ranked researchers
- Rank in Spain
- #25,757 of 204,306
- Works
- 27
- Citations
- 1.9k
- Citations per work
- 72.1
What does Anna Planagumà research?
Anna Planagumà's work is mostly in Medicine (40%), Biochemistry, Genetics and Molecular Biology (13%), Pharmacology, Toxicology and Pharmaceutics (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1140.3%
- Medicine1140.3%
- Everything else1140.2%
- Life Sciences519.5%
- 1Pharmacology14% of their works
- 2Biochemistry13% of their works
- 3Physiology12% of their works
- 4Hepatology8% of their works
- 5Oncology6% of their works
- 6Pharmacology6% of their works
Research topics
- Eicosanoids and Hypertension Pharmacology
- Inflammatory mediators and NSAID effects
- Asthma and respiratory diseases
- Drug-Induced Hepatotoxicity and Protection
- Liver physiology and pathology
- Peroxisome Proliferator-Activated Receptors
- Liver Disease Diagnosis and Treatment
- Drug Transport and Resistance Mechanisms
Which keywords describe Anna Planagumà's research?
The keywords of their largest research topics: Inflammation, Metabolism, Arachidonic Acid, Epoxyeicosatrienoic Acids, Oxidative Stress, Cancer, Cyclooxygenase-2 Inhibitors and Allergic Diseases.
- Peroxisome Proliferator-Activated Receptors
- NASH
- Multidrug Resistance
- Liver Regeneration
- Hepatic Stellate Cells
- Nuclear Receptors
- Allergic Diseases
- Cancer
- Epoxyeicosatrienoic Acids
- Metabolism
- Inflammation
- Arachidonic Acid
- Oxidative Stress
- Cyclooxygenase-2 Inhibitors
- Asthma
- Drug-Induced Liver Injury
- Hepatotoxicity
- ATP-dependent Transporters
- NAFLD
- PPARs
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 20 words, with their numbers
- Inflammation335 topics
- Metabolism132 topics
- Arachidonic Acid101 topic
- Epoxyeicosatrienoic Acids101 topic
- Oxidative Stress102 topics
- Cancer91 topic
- Cyclooxygenase-2 Inhibitors91 topic
- Allergic Diseases61 topic
- Asthma61 topic
- Nuclear Receptors62 topics
- Drug-Induced Liver Injury51 topic
- Hepatic Stellate Cells51 topic
- Hepatotoxicity51 topic
- Liver Regeneration51 topic
- ATP-dependent Transporters31 topic
- Multidrug Resistance31 topic
- NAFLD31 topic
- NASH31 topic
- PPARs31 topic
- Peroxisome Proliferator-Activated Receptors31 topic
Where does Anna Planagumà work?
Anna Planagumà's main affiliation in the publication record is Universitat de Barcelona, Spain.
How many publications and citations does Anna Planagumà have?
OpenAlex counts 27 works and 1,946 citations for Anna Planagumà, an h-index of 18, ranking #1,264,391 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Anna Planagumà. Posts are plain text and can be reported.